We leverage Minor Intron splicing to treat therapy resistant cancers

Welcome to the pinnacle of biotechnology innovation, where cutting-edge research in a rare class of introns called minor introns meets unparalleled expertise in RNA biology and oncology. Our commitment to excellence fuels the discovery of transformative solutions that redefine the possibilities in treating therapy resistant prostate, breast and other cancers.